Literature DB >> 6600367

Importance of complete revascularization in performance of the coronary bypass operation.

E L Jones, J M Craver, R A Guyton, D K Bone, C R Hatcher, N Riechwald.   

Abstract

Cardiac Data Bank records of 1,238 patients with triple-vessel disease (greater than or equal to 50% diameter reduction) who had undergone coronary bypass surgery were reviewed and divided into 2 groups depending on whether complete (n = 773) or incomplete (n = 465) revascularization had been accomplished. Patients with complete revascularization had a higher incidence of a normal preoperative electrocardiogram than did patients with incomplete revascularization (23 versus 14%, respectively, p less than 0.0001). The ejection fraction for both completely and incompletely revascularized patients was good (m = 0.60 and 0.57, respectively). The mean number of grafts per patient for the 2 groups was 3.8 and 2.6 (p less than 0.0001). There was no significant difference between the 2 groups with regard to postoperative inotropic requirements (8 and 7%), ventricular arrhythmias (1.8 and less than 1%), necessity for intraaortic balloon pumping (1.6 and 1.5%, hospital mortality (1.2 and 2.8%), or myocardial infarction (4.3 and 4.8%). Survival at 5 years was significantly greater (p less than 0.001) in patients with complete (88.5%) than in those with incomplete revascularization (83.5%). Reemployment occurred more often in patients with complete (52%) than in those with incomplete revascularization (40%) (p less than 0.001), and more patients were free of angina after complete (70%) than after incomplete revascularization (58%) (p less than 0.0005). Long-term survival appeared to be mediated primarily through improved revascularization rather than through differences in left ventricular function.

Entities:  

Mesh:

Year:  1983        PMID: 6600367     DOI: 10.1016/s0002-9149(83)80003-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

1.  Therapeutic Angiogenesis for Coronary Artery Disease.

Authors:  Tanveer A. Khan; Frank W. Sellke; Roger J. Laham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-02

2.  Detection and management of concomitant coronary artery disease in patients undergoing thoracic aortic surgery.

Authors:  T Ueda; H Shimizu; H Shin; I Kashima; K Tsutsumi; Y Iino; R Yozu; S Kawada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-07

3.  Patient selection and technical considerations for off-pump coronary surgery.

Authors:  Amit N Patel; Federico Benetti; Baron Hamman
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-07

Review 4.  Radial artery graft vs. saphenous vein graft for coronary artery bypass surgery : which conduit offers better efficacy?

Authors:  H Zhang; Z W Wang; H B Wu; X P Hu; Z Zhou; P Xu
Journal:  Herz       Date:  2013-06-21       Impact factor: 1.443

Review 5.  Incomplete revascularization: what the surgeon needs to know.

Authors:  Dror B Leviner; Gianluca Torregrossa; John D Puskas
Journal:  Ann Cardiothorac Surg       Date:  2018-07

6.  Determinants of 10-year survival after primary myocardial revascularization.

Authors:  D M Cosgrove; F D Loop; B W Lytle; C C Gill; L A Golding; C Gibson; R W Stewart; P C Taylor; M Goormastic
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

7.  Percutaneous transluminal coronary angioplasty in patients 70 years of age or older: 12 years' experience.

Authors:  K H Tan; N Sulke; N Taub; S Karani; E Sowton
Journal:  Br Heart J       Date:  1995-09

Review 8.  Pharmacotherapy for end-stage coronary artery disease.

Authors:  Neel R Sodha; Louis M Chu; Munir Boodhwani; Frank W Sellke
Journal:  Expert Opin Pharmacother       Date:  2010-02       Impact factor: 3.889

9.  Immediate and long term results of percutaneous coronary angioplasty in patients aged 70 and over.

Authors:  P de Jaegere; P de Feyter; R van Domburg; H Suryapranata; M van den Brand; P W Serruys
Journal:  Br Heart J       Date:  1992-02

Review 10.  Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.

Authors:  Munir Boodhwani; Frank W Sellke
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.